hydrocortisone probutate

hydrocortisone probutate (PANDEL) is an FDA-listed pharmaceutical active ingredient. Route of administration: topical. Current US regulatory status: approved.

PANDEL is a marketed brand name for hydrocortisone probutate. Check FDA Drugs@FDA for the current US label holder and prescribing information.

hydrocortisone probutate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.